Impact of COVID-19 on Nonpulmonary Critical Illness: Prevalence, Clinical Manifestations, Management, and Outcomes
- PMID: 37085218
- PMCID: PMC9682059
- DOI: 10.1016/j.ccm.2022.11.011
Impact of COVID-19 on Nonpulmonary Critical Illness: Prevalence, Clinical Manifestations, Management, and Outcomes
Abstract
Although respiratory manifestations are the most common driver of hospitalization, SARS-CoV-2 infection has a wide range of manifestations, including multisystem organ failure in severe cases. This review discusses the prevalence, pathophysiology, clinical manifestations, treatment, and outcomes of nonpulmonary organ dysfunction from SARS-CoV2, including renal, liver, cardiac, neurologic, and coagulation system dysfunction. At this time, management largely focuses on supportive care practices that are applicable regardless of the cause of organ injury.
Keywords: COVID-19; Critical illness; Organ failure; Sepsis.
Published by Elsevier Inc.
Figures
References
-
- Coronavirus World Map: tracking the global outbreak. the New York times. https://www.nytimes.com/interactive/2021/world/covid-cases.html?smid=url... Available at: Updated May 1, 2022. Accessed May 1, 2022, 2022.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
